A substantial body of evidence supports the safety of the COVID-19 vaccines during pregnancy, contrary to the suggestions of ...

The government is funding respected scholars to study autism’s causes, at a time when experts say it’s also sowing ...

On November 4, 2024, Karolinska Institutet (KI) hosted the symposium "Beyond Amyloid and Tau: The Importance of ...

DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced ...

SAN FRANCISCO and BOSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for ...

The Australian Medical Association NSW president has said stark figures were buried in the Bureau of Health Information's new report and questioned the presentation of data. The bureau has said it ...

People get bored fast. That’s what scientists have concluded from studies of presentations in different venues, from the classroom to remote meetings. But exactly how quickly do people lose interest?

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic ...

UK biotech Scancell has reported data from a phase 2 trial of its off-the-shelf DNA plasmid vaccine for melanoma that it says backs a swift move to a larger, registrational study. The SCOPE trial of ...

Preliminary annual revisions could add to political pressure on the agency that produces the data. Preliminary annual revisions by the Bureau of Labor Statistics show that 911,000 fewer jobs were ...

LA JOLLA, CA, Sept. 11, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell ...